Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash | RSS News Feed

Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash - Latest News

RSS Feed for this news: Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash

Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE:FRX) today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal (GI) and Cystic Fibrosis company, for $2.9 billion in ... read more

Forest Labs (FRX) to Acquire Privately-Held Aptalis in $2.9B Deal

Forest Laboratories, Inc. (NYSE: FRX) announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal (GI) and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders ... read more

Actavis To Acquire Forest Labs For $25 Billion [REPORT]

Actavis PLC is in talks to acquire Forest Laboratories ... and gastroenterology products. Forest Labs acquired Aptalis just last month for $2.9 billion in cash. Uncertainties about the US healthcare market and fierce competition from generic drug ... read more

Looking for another news?


Forest Laboratories - Aptalis Deal Sparks More Enthusiasm

Acquisition Of Aptalis Forest Laboratories announced that it will acquire Aptalis for $2.9 billion in cash. Forest will acquire the privately held company from private investment firm TPG, among others. Aptalis focuses on specialty gastrointestinal ... read more

Forest Labs buying Aptalis for $2.9 billion

NEW YORK (AP) -- Forest Laboratories is buying Aptalis, which specializes in treatments for gastrointestinal problems and cystic fibrosis, for $2.9 billion in cash. Shares of Forest Labs surged in premarket trading Wednesday. Forest Labs President and CEO ... read more

Forest Labs To Acquire Furiex Pharma A Deal Potentially Worth $1.46 Billion

This afternoon, Forest ... 2.9 billion acquisition of Aptalis earlier this year,” said Brent Saunders, Chief Executive Officer and President of Forest Laboratories, Inc. Furiex is a drug development collaboration company, and Forest has agreed to acquire ... read more

Forest Labs to Buy Furiex Pharmaceuticals

The wave of deal-making in the drug industry continued on Monday when Forest Laboratories agreed to acquire Furiex Pharmaceuticals for up ... of our G.I. business following our $2.9 billion acquisition of Aptalis earlier this year.” read more

Forest Labs Soars on Aptalis Deal

Forest Laboratories, Inc. (NYSE:FRX) announced its intention to acquire U.S. based privately-held Aptalis for $2.9 billion in cash. The acquisition, which is expected to be immediately accretive, is slated to go through in the first half of 2014. read more

Aptalis to be Acquired by Forest Laboratories for $2.9 Billion

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Aptalis, a privately-held leading specialty pharmaceutical company, today announced that it has signed a definitive agreement to be acquired by Forest Laboratories ... for $2.9 billion in cash, pending required reviews ... read more


FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us